Anthracyclines in the treatment of early-stage breast cancer: ally or adversary?

Cancer Invest. 2010 Mar;28(3):217-9. doi: 10.3109/07357901003640404.
No abstract available

MeSH terms

  • Anthracyclines / administration & dosage
  • Anthracyclines / adverse effects
  • Anthracyclines / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant
  • Clinical Trials as Topic
  • Female
  • Humans
  • Neoplasm Staging

Substances

  • Anthracyclines